Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-01-02 Sale | 2024-01-04 5:16 pm | Royalty Pharma plc | RPRX | RIGGS RORY B Director | 470,000 | $28.13 | $13,222,862 | 120,286 (Indirect Direct) | View |
2023-12-29 Sale | 2024-01-03 4:31 pm | Royalty Pharma plc | RPRX | Avara Management Ltd Giuliani Mario Germano 10% Owner | 65,803 | $28.04 | $1,845,406 | 32,555,339 (Indirect Direct) | View |
2023-12-27 Sale | 2023-12-29 4:29 pm | Royalty Pharma plc | RPRX | Avara Management Ltd Giuliani Mario Germano 10% Owner | 251,592 | $28.17 | $7,087,688 | 32,621,142 (Indirect Direct) | View |
2023-12-15 Sale | 2023-12-19 4:30 pm | Royalty Pharma plc | RPRX | Avara Management Ltd Giuliani Mario Germano 10% Owner | 10,229 | $28.01 | $286,499 | 32,872,734 (Indirect Direct) | View |
2023-12-13 Sale | 2023-12-15 4:31 pm | Royalty Pharma plc | RPRX | Avara Management Ltd Giuliani Mario Germano 10% Owner | 672,376 | $28.93 | $19,450,288 | 32,882,963 (Indirect Direct) | View |
2023-08-09 Sale | 2023-08-11 5:00 pm | Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO | 75,000 | $30.73 | $2,305,028 | 840,390 (Indirect Direct) | View |
2023-07-12 Sale | 2023-07-14 6:09 pm | Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO | 75,000 | $31 | $2,325,214 | 915,390 (Indirect Direct) | View |
2023-06-28 Purchase | 2023-06-28 4:01 pm | Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board 10% Owner | 130,000 | $29.51 | $3,836,768 | 3,758,980 (Indirect Direct) | View |
2023-06-12 Purchase | 2023-06-13 4:01 pm | Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board 10% Owner | 90,000 | $32.89 | $2,959,848 | 3,628,980 (Indirect Direct) | View |
2023-06-02 Sale | 2023-06-06 5:07 pm | Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & CLO | 192,221 | $33.7 | $6,478,587 | 806,831 (Indirect Direct) | View |
2023-05-24 Purchase | 2023-05-24 6:45 pm | Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board 10% Owner | 150,000 | $32.25 | $4,837,440 | 3,538,980 (Indirect Direct) | View |
2023-05-22 Sale | 2023-05-22 8:36 pm | Royalty Pharma plc | RPRX | RIGGS RORY B Director | 1,750,000 | $32.82 | $57,435,000 | 106,949 (Indirect Direct) | View |
2023-05-16 Purchase | 2023-05-17 6:41 pm | Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board 10% Owner | 230,000 | $33.38 | $7,676,824 | 3,388,980 (Indirect Direct) | View |
2023-03-29 Sale | 2023-03-30 5:53 pm | Royalty Pharma plc | RPRX | RIGGS RORY B Director | 139,950 | $36.31 | $5,081,111 | 1,556,949 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-02-20 Conversion | 2024-02-22 7:23 pm | N/A N/A | Royalty Pharma plc | RPRX | RIGGS RORY B Director | 330,000 | $0 | 690,286 (Direct) | View |
2023-12-29 Option Award | 2023-12-29 5:14 pm | N/A N/A | Royalty Pharma plc | RPRX | Fernandez Henry A Director | 1,353 | $27.71 | 98,928 (Direct) | View |
2023-12-29 Option Award | 2023-12-29 5:11 pm | N/A N/A | Royalty Pharma plc | RPRX | Bassler Bonnie L Director | 1,353 | $27.71 | 46,522 (Direct) | View |
2022-12-30 Gift | 2023-11-16 5:50 pm | N/A N/A | Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board 10% Owner | 292,190 | $0 | 4,051,170 (Indirect) | View |
2023-11-16 Other | 2023-11-16 5:50 pm | N/A N/A | Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board 10% Owner | 383,000 | $0 | 4,051,170 (Direct) | View |
2023-11-13 Conversion | 2023-11-14 7:35 pm | N/A N/A | Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & CLO | 165,000 | $0 | 1,412,983 (Indirect) | View |
2023-11-13 Conversion | 2023-11-14 5:17 pm | N/A N/A | Royalty Pharma plc | RPRX | RIGGS RORY B Director | 523,149 | $0 | 890,286 (Direct) | View |
2023-09-29 Option Award | 2023-10-03 4:25 pm | N/A N/A | Royalty Pharma plc | RPRX | Fernandez Henry A Director | 1,384 | $27.08 | 97,575 (Direct) | View |
2023-09-29 Option Award | 2023-10-03 4:23 pm | N/A N/A | Royalty Pharma plc | RPRX | Bassler Bonnie L Director | 1,384 | $27.08 | 45,169 (Direct) | View |
2023-08-08 Gift | 2023-08-08 5:39 pm | N/A N/A | Royalty Pharma plc | RPRX | RIGGS RORY B Director | 6,500 | $0 | 347,559 (Direct) | View |
2023-08-08 Gift | 2023-08-08 5:37 pm | N/A N/A | Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO | 1,650 | $0 | 351,350 (Indirect) | View |
2023-08-08 Gift | 2023-08-08 5:36 pm | N/A N/A | Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & CLO | 5,555 | $0 | 431,152 (Direct) | View |
2023-06-30 Option Award | 2023-06-30 09:15 am | N/A N/A | Royalty Pharma plc | RPRX | Fernandez Henry A Director | 1,208 | $31.03 | 96,191 (Direct) | View |
2023-06-30 Option Award | 2023-06-30 09:12 am | N/A N/A | Royalty Pharma plc | RPRX | Bassler Bonnie L Director | 1,208 | $31.03 | 43,785 (Direct) | View |
2023-06-23 Option Award | 2023-06-27 4:30 pm | N/A N/A | Royalty Pharma plc | RPRX | Giuliani Mario Germano Director 10% Owner | 7,747 | $0 | 33,555,339 (Direct) | View |
2023-06-23 Option Award | 2023-06-26 4:14 pm | N/A N/A | Royalty Pharma plc | RPRX | RIGGS RORY B Director | 7,747 | $0 | 114,696 (Direct) | View |
2023-06-23 Option Award | 2023-06-26 4:12 pm | N/A N/A | Royalty Pharma plc | RPRX | Norden Gregory Director | 7,747 | $0 | 64,445 (Direct) | View |
2023-06-23 Option Award | 2023-06-26 4:11 pm | N/A N/A | Royalty Pharma plc | RPRX | LOVE TED W Director | 7,747 | $0 | 36,941 (Direct) | View |
2023-06-23 Option Award | 2023-06-26 4:09 pm | N/A N/A | Royalty Pharma plc | RPRX | HODGSON DAVID C Director | 7,747 | $0 | 16,421 (Direct) | View |
2023-06-23 Option Award | 2023-06-26 4:07 pm | N/A N/A | Royalty Pharma plc | RPRX | Fernandez Henry A Director | 7,747 | $0 | 94,983 (Direct) | View |
2023-06-23 Option Award | 2023-06-26 4:05 pm | N/A N/A | Royalty Pharma plc | RPRX | Engelbert Catherine M. Director | 7,747 | $0 | 33,211 (Direct) | View |
2023-06-23 Option Award | 2023-06-26 4:04 pm | N/A N/A | Royalty Pharma plc | RPRX | DESOUZA ERROL B Director | 7,747 | $0 | 64,445 (Direct) | View |
2023-06-23 Option Award | 2023-06-26 4:02 pm | N/A N/A | Royalty Pharma plc | RPRX | Bassler Bonnie L Director | 7,747 | $0 | 42,577 (Direct) | View |
2023-05-12 Gift | 2023-05-15 9:34 pm | N/A N/A | Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board 10% Owner | 20,538 | $0 | 1,700,189 (Indirect) | View |
2023-05-09 Conversion | 2023-05-12 6:43 pm | N/A N/A | Royalty Pharma plc | RPRX | RIGGS RORY B Director | 330,000 | $0 | 2,211,008 (Direct) | View |
2023-03-31 Option Award | 2023-03-31 4:40 pm | N/A N/A | Royalty Pharma plc | RPRX | Fernandez Henry A Director | 1,049 | $35.73 | 87,236 (Direct) | View |
2023-03-31 Option Award | 2023-03-31 4:38 pm | N/A N/A | Royalty Pharma plc | RPRX | Bassler Bonnie L Director | 1,049 | $35.73 | 34,830 (Direct) | View |